Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting-edge healthcare segment.
3 Reasons to Buy the Dip on Microsoft Stock Microsoft's recent 10% sell-off offers a great potential stock-buying opportunity.
Does Chipotle Really Deserve Its Premium Valuation Anymore? With management forecasting flat comparable restaurant sales in 2026, the burrito chain stock's recent rebound may be called into question.
Is Amphenol Stock the Next Big Opportunity? Here's What You Need to Know. Could Amphenol be the next big winner in the tech sector? Join us as we explore its strengths, management, and financials to see if this stock is worth your investment.
Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook Novo Nordisk dropped after management forecasts weaker 2026 growth, shifting attention from recent results to pricing pressure and rising competition in obesity treatments.
The Smartest Growth Stock to Buy With $30 Right Now This pre-revenue biopharmaceutical stock is a home run swing worth taking.
Stock Market Today, Feb. 3: Rocket Companies Rallies on Signs of Mortgage Demand Recovery Rocket Companies advanced after its CEO said mortgage loan production has reached a four-year high, as the market revisits the outlook for housing demand.
Is e.l.f. Beauty Stock a Hidden Gem in the Cosmetics Aisle? E.l.f. Beauty is growing its top line rapidly by attracting cost-conscious consumers.
XAU/USD Recovers Above $4,950 As US-Iran Tensions Boost Safe-Haven Demand Gold price (XAU/USD) trades in positive territory near $4,985 during the early Asian session on Wednesday.
Stock Market Today, Feb. 3: PayPal Plunges After Earnings Miss and Weak 2026 Profit Outlook Today, Feb. 3, 2026, investors are weighing a rare earnings stumble against fresh leadership, buybacks, and a balance-sheet reset.
